JAVADIN
Live / Applied — First extension granted (statement of use) (as of 30 Sept 2025)
What this means for you
Not registered yet, but its 21 Jan 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99013829
- Mark type
- Stylized text
- Filed
- 21 Jan 2025
- Published for opposition
- 04 Mar 2025
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating hypertension
Owner
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
- Azurity Pharmaceuticals, Inc., Woburn, MA, US
Prosecution history
- 12 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2025 — SOU EXTENSION 1 GRANTED
- 30 Sept 2025 — SOU EXTENSION 1 FILED
- 30 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Mar 2025 — PUBLISHED FOR OPPOSITION
- 04 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Feb 2025 — ASSIGNED TO EXAMINER
- 21 Jan 2025 — APPLICATION FILING RECEIPT MAILED
- 21 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Jan 2025 — NEW APPLICATION ENTERED